EOLS (Evolus) Float Percentage Of Total Shares Outstanding: 98.76% (As of Jul. 02, 2026)


EOLS Evolus Inc EOLS
66 GF Score
Price $6.82
GF Value $13.62
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Evolus Float Percentage Of Total Shares Outstanding?

Evolus EOLS +0.96% 66 Float Percentage Of Total Shares Outstanding is 98.76% as of Jul. 02, 2026. GuruFocus rates EOLS with a GF Score™ of 66/100 and a GF Value™ of $13.62 (Possible Value Trap). The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Evolus's float shares is 65.03 Mil. Evolus's total shares outstanding is 65.85 Mil. Evolus's float percentage of total shares outstanding is 98.76%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Evolus's Insider Ownership is 4.54%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Evolus's Institutional Ownership is 74.44%.

EOLS
66GF Score
Evolus Inc EOLS
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evolus Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Evolus's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=65.03/65.85
=98.76%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 98.76% mean?
Evolus (EOLS) has a Float Percentage Of Total Shares Outstanding of 98.76% as of Jul. 02, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Evolus and its competitors.
Is Evolus' Float Percentage Of Total Shares Outstanding too high?
Evolus' current Float Percentage Of Total Shares Outstanding is 98.76%. Overall, Evolus has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolus' Float Percentage Of Total Shares Outstanding compare to NIKA and EBS?
Evolus' Float Percentage Of Total Shares Outstanding of 98.76% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Evolus and its competitors. Evolus's current Float Percentage Of Total Shares Outstanding is 98.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolus stock overvalued right now?
Based on GuruFocus' analysis, Evolus (EOLS) is currently considered Possible Value Trap. The stock's GF Value™ is $13.62, compared to a current price of $6.82 — trading 50% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 98.76%. Evolus' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Evolus (EOLS), the current Float Percentage Of Total Shares Outstanding is 98.76% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evolus (EOLS) Overvalued in 2026?

Based on GuruFocus' analysis, Evolus stock appears to be undervalued. The current stock price of $6.82 is trading 50% below its estimated GF Value™ of $13.62. GuruFocus considers Evolus to be Possible Value Trap.

Key valuation signals for EOLS:

  • Float Percentage Of Total Shares Outstanding: 98.76%
  • GF Value™: $13.62 vs. price of $6.82 (50% below fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the EOLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Evolus Business Description

Other Exchanges EVL:Germany
Address 520 Newport Center Drive, Suite 1200, Newport Beach, CA, USA, 92660
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
66GF Score

Get the complete analysis for EOLS

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.82
Price
$13.62
GF Value